Numerous effects of IL-1 have been linked to AD, including increased levels of neuronal Aβ precursor protein and other proteins associated with plaques, promotion of astrocyte activation, and astrocytic upregulation of S100B [65]. This evidence concerns the gene IL1A and Alzheimer disease.